Highlights Archive – Page 2

Highlights Highlights Archive

Study: Antibiotic resistance threatens 30-year decline in deaths from lower respiratory infections

A new global analysis warns that antibiotic resistance is undermining decades of progress against lower respiratory infections (LRIs), including pneumonia and bronchiolitis. Using data from the Global Burden of Disease Study, researchers found that while overall LRI deaths fell from 4.3 million in 1990 to 3.5 million in 2021, drug-resistant infections now account for a growing share of fatalities. In…

Ben KempMarch 2, 2026

Highlights Highlights Archive

Multi-cancer blood test doesn’t meet key objective in NHS trial

A major NHS trial of the Galleri blood test has not met its main objective, according to its developer, Grail. The test, which is being evaluated in around 142,000 patients, aims to detect up to 50 types of cancer through a simple blood sample — often before symptoms appear. The trial was designed to determine whether the test could reduce…

Ben KempMarch 2, 2026

Highlights Highlights Archive

Media Monitoring: 5th – 18th February

UK launches plan to tackle 'forever chemicals' amid growing concerns The UK is to increase testing for so-called "forever chemicals" in the environment as part of a national plan to tackle the substances, which have prompted environmental and health concerns. The group of chemicals, also known as PFAS, are used in many everyday products because of their oil resistant and…

Ben KempFebruary 17, 2026

Highlights Highlights Archive

UCL: Early diagnosis key to improving childhood cancer survival

A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children’s cancer has spread at diagnosis in a way that can be compared between countries. While poorer survival following late-stage diagnosis is well recognised, the study is the first to show that differences in…

Ben KempFebruary 17, 2026

Highlights Highlights Archive

Media Monitoring: 22nd January – 4th February

NHS launches trailblazing AI and robot pilot to spot lung cancer sooner alongside screening programme set to tackle cancer inequalities Patients facing suspected lung cancer could get answers sooner under a new NHS pilot using artificial intelligence and robotic technology to help doctors reach hard-to-detect cancers earlier, with fewer invasive tests. The new approach uses AI software to rapidly analyse lung scans and flag small lumps…

Ben KempFebruary 3, 2026

Highlights Highlights Archive

Blood test predicts response to breast cancer treatment

New research suggests that a simple blood test could help predict how patients with advanced breast cancer will respond to targeted treatments, even before therapy starts. Scientists found that measuring tiny fragments of cancer DNA circulating in the bloodstream may offer early clues about whether a treatment is likely to be effective. The study was carried out by researchers at…

Ben KempFebruary 3, 2026

Highlights Highlights Archive

Groundbreaking study could lead to diabetes screening for children

Researchers suggest that all children in the UK could one day be routinely screened for type 1 diabetes using a quick finger-prick blood test, following encouraging results from a large national study. At present, many children are not diagnosed until they become seriously unwell. This puts them at risk of diabetic ketoacidosis, a dangerous condition that requires emergency hospital care.…

Ben KempFebruary 3, 2026

Highlights Highlights Archive

Government announces new three-year Neighbourhood Early Diagnosis Fund for cancer

Patients in deprived and underserved areas will receive potentially life-saving earlier cancer diagnosis through a new £200 million scheme to tackle postcode lotteries in cancer care. Local communities across England will benefit from the major investment, aimed at reducing cancer screening inequalities and catching more cancers early. From 2026, Cancer Alliances - regional NHS partnerships that co-ordinate cancer services -…

Ben KempFebruary 3, 2026

Highlights Highlights Archive

Media Monitoring: 7th – 21st January

New European initiative seeks to accelerate timely Alzheimer's disease diagnosis and treatment The ACCESS-AD consortium, which is co-led by King’s College London, Amsterdam UMC, Siemens Healthineers and Gates Ventures, and funded by the European Commission’s Innovative Health Initiative, has announced the launch of a transformative European initiative which has an initial budget of over €38 million over 5 years…

Ben KempJanuary 20, 2026

Highlights Highlights Archive

Professor Chris Molloy to become BIA CEO from May

The BioIndustry Association (BIA) have announced that Professor Chris Molloy will become their Chief Executive from May 2026. Chris currently serves as the founding Chief Executive Officer of the Medicines Discovery Catapult (MDC), bringing together organisations across academia, industry, the NHS and private capital to drive innovation for patients in the UK and beyond. During the COVID-19 pandemic, Chris was responsible…

Ben KempJanuary 20, 2026